About Histogen

Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets that replace and regenerate tissues in the body. The Company currently has three product candidates addressing underserved, multi-billion dollar global markets: a dermal filler, a treatment for hair loss, and a treatment for joint cartilage repair.


Histogen, Inc., a Delaware Corporation, was founded in 2007 to develop innovative products utilizing the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.

Histogen founder Dr. Gail Naughton is a highly respected scientist with extensive experience in the field of tissue engineering and regenerative medicine. Dr. Naughton discovered the potential of proteins and growth factors produced by hypoxia-induced multipotent cells for therapeutic and biomedical applications, and developed Histogen’s unique technology process to create products based on these proteins. The technology is protected by patent families filed in the US and across key geographies.


Our Mission

To redefine regenerative medicine by developing high value therapeutic and aesthetic products that stimulate the body’s own stem cells to regenerate tissues, without the use of embryonic stem cells or animal components.


Histogen’s Executive Management team has decades of experience in bringing cell-based regenerative products from concept to market. In addition, the Company’s Board of Directors and Scientific Advisors are leaders in the fields of regenerative medicine and global marketing and business operations. Histogen has brought on experienced consultants to advise the team in regulatory, quality and production areas.

Board of Directors

Latest News

Recent & Upcoming Events

September 8-10, 2019

H.C. Wainwright Global Investment Conference

New York, NY
Richard Pascoe, Chairman and CEO, will provide an overview of Histogen's business during a live presentation.
October 22, 2019

2019 BIO Investor Forum

San Francisco, CA
Histogen Chairman & CEO Richard Pascoe to present
January 13-15, 2020

Biotech Showcase

San Francisco, CA
Histogen Chairman & CEO Richard Pascoe to present.


No current openings